Healthcare
India moves closer to dengue vaccine as final trials underway
An Indian vaccine candidate, DengiAll, is in its final testing phase. This single-dose shot offers hope against the deadly dengue disease. Over 10,000 volunteers are participating in the trials. If successful, DengiAll could be available next year. This development is crucial for India and other lower-middle-income countries facing rising dengue cases.
Navigating environmental shifts: How proactive hygiene shapes a child's future
In today's unpredictable climate, raising children requires a proactive approach to health beyond traditional methods. Savlon Swasth India Mission's podcast, The Doc's Pod, emphasizes science-backed hygiene practices as a strategic tool for physical empowerment. By integrating habits like regular handwashing and surface sanitization, families can build a robust foundation for enduring health and cognitive development.
Dräger India collaborates with Breach Candy Hospital to advance clinical education
Dräger India and Breach Candy Hospital have partnered to enhance clinical education and skill development for healthcare professionals. This collaboration brings the Dräger Medical Academy to Mumbai, offering digital learning modules and VR-based simulation training to bridge skill gaps and improve patient safety. The initiative aims to foster continuous learning and readiness in India's evolving healthcare landscape.
Centre plans free HPV vaccine for girls under national immunisation programme
India is launching a nationwide HPV vaccination program for 14-year-old girls, offering the free and voluntary Gardasil vaccine to combat cervical cancer. This initiative aims to eliminate the disease, which remains a significant health concern for women in the country. Vaccinations will be administered at designated government health facilities.
Torrent Group ventures into diagostics business, opens lab in Navi Mumbai
Torrent Group has entered the diagnostics market. They have launched Torrent Diagnostics and opened India's largest National Reference Laboratory in Navi Mumbai. This 100,000 sq ft facility supports 15 diagnostic disciplines and over 3,500 tests. It offers advanced capabilities like Next Generation Sequencing and BSL-3 containment. The lab is staffed by a skilled scientific and technical team.
Torrent Group forays into diagnostics with Navi Mumbai mega lab
Torrent Group has launched its diagnostics business. The company has opened India's largest National Reference Laboratory in Navi Mumbai. This facility supports over 3,500 test modalities across 15 disciplines. Torrent aims for a strong scientific foundation and wide test offerings. This marks a significant expansion for the Gujarat-based conglomerate.
Why children across India are getting ill more often, and how parents can respond
India's children are facing a new health reality with frequent illnesses linked to climate change. Experts highlight how extreme weather and pollution stress developing immune systems, making them vulnerable. The Savlon Swasth India Mission emphasizes proactive defence through nutrition and hygiene to build resilience against these environmental challenges.
Quality Care India plans to invest Rs 600 crore to set up healthcare facility in Nagpur
Quality Care India Limited is set to invest Rs 600 crore in a new 350+ bed multi-speciality hospital in Nagpur. The facility, to be developed on Maha-Metro land near Kasturchand Park Metro Station, aims to strengthen healthcare infrastructure in Central India. This project, a public-private partnership, is expected to create over 1,500 jobs and enhance regional healthcare capacity.
Indian drugmaker Sai Life Sciences to boost headcount by about 20% amid global demand upswing
Sai Life Sciences will boost its workforce by over 700 employees next financial year. This expansion supports growing global demand for its services. The company is increasing capacity to meet this demand. New hires will focus on scientific, technical, and management roles. This move reflects a broader trend of global pharma companies expanding in India.
Thyroid, antibiotic drugs face fresh safety warnings after national review
New safety warnings are coming for two common medicines, doxycycline and carbimazole. Indian drug regulators have identified potential mental health side effects for doxycycline. Carbimazole will now carry stronger warnings about a rare but serious blood disorder. Manufacturers must update prescribing information. These changes aim to improve patient safety by highlighting important risks.
RECENT NEWS
- 27 Indian-flagged ships remain stranded in Persian Gulf, one starts moving: Government official
- West Asia crisis: The Indians caught in the crossfire
- Iran clears safe passage to Indian ships, vessel with 40,000 metric tonnes of LPG crosses Strait of Hormuz
- IndiGo flights to get costlier as airline announces fuel charge upto Rs 2300 amid West Asia conflict
- Google Maps has two new features, now you can ask the way by speaking with the help of AI.
